Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2002
05/02/2002EP1200602A1 Dsp-11 dual-specificity map kinase phophatase
05/02/2002EP1200595A2 Myxoma virus genes for immune modulation
05/02/2002EP1200594A2 Protective antigen of epstein barr virus
05/02/2002EP1200591A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity
05/02/2002EP1200590A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
05/02/2002EP1200585A1 T-cell receptor gamma alternate reading frame protein, (tarp) and uses thereof
05/02/2002EP1200584A1 Splice variants of cd40-receptor
05/02/2002EP1200563A1 Attenuated influenza virus useful as vaccine
05/02/2002EP1200562A2 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders
05/02/2002EP1200559A2 Muscle cells and their use in cardiac repair
05/02/2002EP1200479A1 Multiple cytokine-antibody complexes
05/02/2002EP1200477A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein
05/02/2002EP1200476A1 Antitumor antibodies, proteins, and uses thereof
05/02/2002EP1200469A2 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
05/02/2002EP1200466A2 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family
05/02/2002EP1200463A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof
05/02/2002EP1200462A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands
05/02/2002EP1200459A1 Compounds for treatment of infectious and immune system disorders and methods for their use
05/02/2002EP1200132A2 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
05/02/2002EP1200126A1 Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections
05/02/2002EP1200125A1 Psca: prostate stem cell antigen and uses thereof
05/02/2002EP1200123A1 Diagnosis and treatment of neuroectodermal tumors
05/02/2002EP1200122A2 Multi-component vaccine to protect against disease caused by haemophilus influenzae and moraxella catarrhalis
05/02/2002EP1200121A2 Fish vaccine
05/02/2002EP1200120A1 Pneumococcal vaccines
05/02/2002EP1200119A2 Method for down-regulating gdf-8 activity
05/02/2002EP1200109A1 Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
05/02/2002EP1200098A2 Combined preparations comprising daunorubicin derivatives and anti her2 antibodies
05/02/2002EP1200074A2 Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes
05/02/2002EP1078018B1 Process for extracting carotenes from carotene-containing materials
05/02/2002EP0879056B1 Modulation of th1/th2 cytokine expression by ribavirin in activated t-lymphocytes
05/02/2002EP0593585B1 Peptide which abrogates tnf and lps toxicity
05/02/2002CA2464228A1 Vaccine immunotherapy for immune suppressed patients
05/02/2002CA2457111A1 Vaccine for treating allergy
05/02/2002CA2431178A1 Baseb209 polypeptides and polynucleotides from haemophilus influenzae
05/02/2002CA2427070A1 Preferred segments of neural thread protein and methods of using the same
05/02/2002CA2426887A1 Polypeptides and polynucleodides from haemophilus influenzae and their use
05/02/2002CA2426779A1 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
05/02/2002CA2426742A1 Haemophilus influenzae basb210 polypeptides and encoding polynucleotides and uses thereof
05/02/2002CA2426738A1 Streptococcal genes
05/02/2002CA2426463A1 Novel aggrecanase molecules
05/02/2002CA2425770A1 Using heat shock proteins to increase immune response
05/02/2002CA2425303A1 Nucleic acids and proteins from streptococcus groups a & b
05/02/2002CA2425000A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
05/01/2002CN1347458A Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
05/01/2002CN1347453A Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
05/01/2002CN1347326A BAFF, inhibitors thereof and their use in modulation of B-cell response
05/01/2002CN1346679A Immobilized isomerous tumor vaccine and its preparing process
05/01/2002CN1346678A Weak epitope dominating system and therapeutic hepatitis B vaccine prepared with it
05/01/2002CN1346677A Medicine for preventing cancer and its application method
04/2002
04/30/2002US6380376 Purity polypeptides
04/30/2002US6380374 Isolated nucleic acid; culture product
04/30/2002US6380363 Antibodies to the Ob receptor
04/30/2002US6380360 Polycystic kidney disease 1 gene and uses thereof
04/30/2002US6380359 Liposomes comprising peptide antigens derived from X protein of hepatitis B virus
04/30/2002US6380183 Treatment of diseases involving cyst formation
04/30/2002US6380157 Administering medicament comprising papillomavirus l2 protein, or a therapeutically effective fragment thereof for therapy of papillomavirus infection
04/30/2002US6379951 Compounds for immunotherapy of breast cancer and methods for their use
04/30/2002US6379913 A polypeptide encoding an amino acid sequence; prevention and therapy for diabetes, inflammatory glomerulonephritis, ischemis renal failure, artherosclerosis, coronary vasoconstriction and ischemic heart disease
04/30/2002US6379905 Fragments of prion proteins
04/30/2002US6379902 Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
04/30/2002US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis
04/30/2002US6379891 A polymerase chain reaction amplification method for detecting enterically transmitted non-a/non-b viral hepatitis in a biological sample
04/30/2002US6379885 Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
04/30/2002US6379699 Liposome having attached target-binding moiety and artherosclerotic plaque interacting moiety
04/30/2002US6379678 Culture product; antiallergens
04/30/2002US6379677 Streptococcus iniae vaccine
04/30/2002US6379676 Enhancing immune response in animals
04/30/2002US6379675 Immunological combination compositions and methods
04/30/2002US6379672 Prevention of infectious diseases with gp96-peptide complexes
04/30/2002US6379671 Using a polypeptide antigen mixture
04/30/2002US6379668 Therapy for autoimmune disease
04/30/2002US6379663 Immunity enhancing lactic acid bacteria
04/30/2002CA2196207C Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression
04/30/2002CA2176929C Vaccine against mumps containing a jeryl-lynn virus strain
04/30/2002CA2151045C Platelet-activating factor acetylhydrolase
04/30/2002CA2071908C Antibody antagonists of human interleukin-4
04/30/2002CA2064689C Stabilized protein or peptide conjugates
04/30/2002CA2020247C Antibodies reactive with human carcinomas
04/27/2002CA2325063A1 Method for detecting antibodies to and antigens of fungal and yeast exposures
04/25/2002WO2002033417A1 Assay for directly detecting a rs virus related biological cell in a body fluid sample
04/25/2002WO2002033119A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
04/25/2002WO2002033114A2 Protein-protein interactions in neurodegenerative diseases
04/25/2002WO2002033113A2 Protein-protein interactions in neurodegenerative diseases
04/25/2002WO2002033112A2 Protein-protein interactions in neurodegenerative diseases
04/25/2002WO2002033100A2 Regulation of human adenylate cyclase, type iv
04/25/2002WO2002033099A2 Human kinases
04/25/2002WO2002033095A2 Regulation of human serine-threonine protein kinase
04/25/2002WO2002033089A2 Ixodes scapularis tissue factor pathway inhibitor
04/25/2002WO2002033084A2 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
04/25/2002WO2002033074A1 Artificial protein having potentiated immunogenicity of epitope
04/25/2002WO2002033062A1 REGULATION OF HUMAN ACYL-CoA DEHYDROGENASE
04/25/2002WO2002033058A2 Novel cysteine proteases and uses thereof
04/25/2002WO2002033050A2 Methods and compositions for promoting the maturation of monocytes
04/25/2002WO2002032963A1 Immunoadjuvant systems
04/25/2002WO2002032961A2 Novel polypeptides and nucleic acids encoding same
04/25/2002WO2002032958A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
04/25/2002WO2002032946A2 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae
04/25/2002WO2002032945A2 Haemophilus influenzae basb206 gene and protein
04/25/2002WO2002032944A2 Basb208 nucleotide and amino acid sequences from haemophilus influenzae